DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.
Yuan LiLe-En LiaoLingheng KongWu JiangJinghua TangKai HanZhenlin HouChenzhi ZhangChi ZhouLinjie ZhangQiaoqi SuiBinyi XiaoWeijian MeiYanbo XuJiehai YuZhigang HongZhizhong PanPeirong DingPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)
In this study, we found that PS can predict the prognosis of patients with stage III low-risk CRC. Besides, it may guide the decision on postoperative adjuvant chemotherapy.